Blood Research

Download original image

Summary of treatment in seven PPCL and two SPCL patients.

a)Not affordable for bortezomib.

Note: Among ten PPCLs, one lost follow-up before start of therapy and two opted against therapy. Out of four SPCLs, two opted against therapy.

Abbreviations: PPCL, primary plasma cell leukemia; SPCL, secondary plasma cell leukemia; CR, complete response; PR, partial response; sCR, stringent CR.

Blood Res 2016;51:23~30 https://doi.org/10.5045/br.2016.51.1.23
© Blood Research
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd